Loading
Latest filing published 31 Jul 2023 for Titan Pharmaceuticals INC. Read the official filing
No signal scores available.
Peter Louis Chasey discloses dealings in Titan Pharmaceuticals Inc to SEC (Form 4). Altogether 2 filings, all relating to 26 July 2023.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 31 July 2023: a share grant, in Titan Pharmaceuticals Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations